These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1000491)

  • 1. Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum.
    Soyka LF; Hunt WG; Knight SE; Foster RS
    Cancer Res; 1976 Dec; 36(12):4425-8. PubMed ID: 1000491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
    Ocenásková J; Mára M; Bednár M; Veselská M; Adamcová D
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):100-6. PubMed ID: 3157461
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic drug metabolizing enzyme activity and tumorigenesis in mice following perinatal exposure to benzo(a)pyrene.
    Soyka LF
    Pediatr Pharmacol (New York); 1980; 1(1):85-96. PubMed ID: 6287393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental aspects of hepatic and extrahepatic drug-metabolizing enzyme systems: microsomal enzymes and components in rabbit liver and lung during the first month of life.
    Fouts JR; Devereux TR
    J Pharmacol Exp Ther; 1972 Nov; 183(2):458-68. PubMed ID: 4404328
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Corynebacterium parvum vaccine on drug metabolism in the mouse.
    Macnee CM; Nimmo-Smith RH
    Dev Biol Stand; 1977 Apr 13-15; 38():427-30. PubMed ID: 608533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effect of sulfamethazine on hepatic mixed function oxidases in rats.
    Kodam KM; Govindwar SP
    Vet Hum Toxicol; 1997 Jun; 39(3):141-6. PubMed ID: 9167242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
    Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
    Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzymes metabolizing xenobiotics in spontaneous tumors in mice].
    Kobliakov VA; Kulikova LN; Politova SN
    Biokhimiia; 1991 Jun; 56(6):1088-95. PubMed ID: 1932340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum.
    Maruyama Y; Coleman MS
    Cancer Res; 1978 Jun; 38(6):1617-20. PubMed ID: 647675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole-induced hepatic lysosomal phospholipidosis: the effect of concurrent barbiturate treatment.
    Pakuts AP; Parks RJ; Paul CJ; Bujaki SJ; Mueller RW
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):55-62. PubMed ID: 2326549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aluminum on the hepatic mixed function oxidase and drug metabolism.
    Bidlack WR; Brown RC; Meskin MS; Lee TC; Klein GL
    Drug Nutr Interact; 1987; 5(1):33-42. PubMed ID: 3105994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of solvents on drug metabolism in vitro.
    Kawalek JC; Andrews AW
    Drug Metab Dispos; 1980; 8(6):380-4. PubMed ID: 6109604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
    Patel JM; Ortiz E; Shiverick KT; Leibman K
    Drug Metab Dispos; 1983; 11(6):620-1. PubMed ID: 6140152
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 18. [The behavior of mixed function oxidases in the liver of the rat on the first day after ligation of the ductus choledochus].
    Putzki H; Reichert B; Leemhuis B; Muckle L
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(3):180-2. PubMed ID: 2087830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-fluorouracil on drug-metabolizing enzymes in the rat.
    Klubes P; Cerna I
    Cancer Res; 1974 May; 34(5):927-31. PubMed ID: 4823903
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of high dietary vitamin A on drug-metabolizing enzyme activities in guinea pig and rabbit.
    Miranda CL; Chhabra RS
    Drug Nutr Interact; 1981; 1(1):55-61. PubMed ID: 6926816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.